Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. [electronic resource]
Producer: 20040930Description: 115-23 p. digitalISSN:- 0888-0018
- Amikacin -- administration & dosage
- Anti-Bacterial Agents -- therapeutic use
- Drug Therapy, Combination -- therapeutic use
- Fever -- drug therapy
- Fungi -- isolation & purification
- Gram-Negative Bacteria -- isolation & purification
- Gram-Positive Bacteria -- isolation & purification
- Hematologic Neoplasms -- complications
- Humans
- Infections -- microbiology
- Meropenem
- Neoplasms -- complications
- Netilmicin -- administration & dosage
- Neutropenia -- drug therapy
- Penicillanic Acid -- administration & dosage
- Piperacillin -- administration & dosage
- Tazobactam
- Thienamycins -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.